최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Neurotoxicology, v.32 no.6, 2011년, pp.879 - 887
Park, K.H. , Choi, N.Y. , Koh, S.H. , Park, H.H. , Kim, Y.S. , Kim, M.J. , Lee, S.J. , Yu, H.J. , Lee, K.Y. , Lee, Y.J. , Kim, H.T.
The neurotoxicity of L-3,4-dihydroxyphenylalanine (L-DOPA), one of the most important drugs for the treatment of Parkinson's disease, still remains controversial, although much more data on L-DOPA neurotoxicity have been presented. Considering the well known neuroprotective effects of erythropoietin...
Journal of the Neurological Sciences Agil 240 31 2006 10.1016/j.jns.2005.08.016 Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa
Brain Research Agnello 952 128 2002 10.1016/S0006-8993(02)03239-0 Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis
Journal of Neurochemistry Bijur 75 2401 2000 10.1046/j.1471-4159.2000.0752401.x Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity
Frontier Bioscience Boje 9 763 2004 10.2741/1268 Nitric oxide neurotoxicity in neurodegenerative diseases
Proceedings of the National Academy Sciences of the United States of America Brines 97 10526 2000 10.1073/pnas.97.19.10526 Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
Blood Broudy 77 2583 1991 10.1182/blood.V77.12.2583.2583 Erythropoietin receptor characteristics on primary human erythroid cells
Journal of Neuroscience Caudle 27 8138 2007 10.1523/JNEUROSCI.0319-07.2007 Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
Proceedings of the National Academy Sciences of the United States of America Celik 99 2258 2002 10.1073/pnas.042693799 Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury
Journal of Biological Chemistry Chen 278 28089 2003 10.1074/jbc.M303094200 Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity
Journal of Neuroscience Chen 28 425 2008 10.1523/JNEUROSCI.3602-07.2008 Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice
Current Drug Targets Cardiovascular Haematological Disorders Chong 3 141 2003 10.2174/1568006033481483 Erythropoietin: cytoprotection in vascular and neuronal cells
Biochemical Journal Davies 351 95 2000 10.1042/0264-6021:3510095 Specificity and mechanism of action of some commonly used protein kinase inhibitors
Molecular Cell Frame 7 1321 2001 10.1016/S1097-2765(01)00253-2 A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation
Experimental Cell Research Ganser 316 737 2010 10.1016/j.yexcr.2010.01.001 Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures
Neuroscience Letters Genc 321 73 2002 10.1016/S0304-3940(02)00041-1 Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro
Proceedings of the National Academy Sciences of the United States of America Gorio 99 9450 2002 10.1073/pnas.142287899 Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma
Amino Acids Gulcin 32 431 2007 10.1007/s00726-006-0379-x Comparison of in vitro antioxidant and antiradical activities of l-tyrosine and l-Dopa
Brain Research Jiang 857 71 2000 10.1016/S0006-8993(99)02364-1 Diphosphorylation and involvement of extracellular signal-regulated kinases (ERK1/2) in glutamate-induced apoptotic-like death in cultured rat cortical neurons
Brain Research Kadota 1254 120 2009 10.1016/j.brainres.2008.11.094 Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis
Journal of Biological Chemistry Kirschenbaum 276 30701 2001 10.1074/jbc.M102849200 Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels
Brain Research Molecular Brain Research Koh 118 72 2003 10.1016/j.molbrainres.2003.07.003 Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3
European Journal of Neurosciences Koh 25 1923 2007 10.1111/j.1460-9568.2007.05471.x Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation
Brain Research Koh 1370 186 2011 10.1016/j.brainres.2010.11.021 Protective effects of statins on L-DOPA neurotoxicity due to the activation of phosphatidylinositol 3-kinase and free radical scavenging in PC12 cell culture
Toxicology Koh 247 112 2008 10.1016/j.tox.2008.02.007 Inhibition of glycogen synthase kinase-3 reduces L-DOPA-induced neurotoxicity
Journal of Neurology Kondo 252 Suppl. 4 IV32 2005 Levodopa therapy from the neuroprotection viewpoint. From a clinical outlook
Cancer Research Lee 63 6885 2003 Protective role of alpha-phenyl-N-t-butylnitrone against ionizing radiation in U937 cells and mice
Journal of Clinical Neurology Lee 5 1 2009 10.3988/jcn.2009.5.1.1 Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy
Current Neurovascular Research Li 3 187 2006 10.2174/156720206778018758 Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB
Brain Research Maharaj 1063 180 2005 10.1016/j.brainres.2005.09.041 l-DOPA administration enhances 6-hydroxydopamine generation
Medicinal Research Review Martinez 22 373 2002 10.1002/med.10011 Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
European Journal of Biochemistry Mayeux 216 821 1993 10.1111/j.1432-1033.1993.tb18203.x Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor
European Journal of Neuroscience McLeod 24 361 2006 10.1111/j.1460-9568.2006.04919.x Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease
Movement Disorders Mena 7 23 1992 10.1002/mds.870070105 Neurotoxicity of levodopa on catecholamine-rich neurons
Journal of Neurology Muller 44 2004 Is levodopa toxic?
Journal of Neurochemistry Mytilineou 61 1470 1993 10.1111/j.1471-4159.1993.tb13642.x Toxic and protective effects of L-dopa on mesencephalic cell cultures
Neuroscience Letters Nakaso 432 146 2008 10.1016/j.neulet.2007.12.034 Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells
Journal of Neurochemistry Noh 108 1116 2009 10.1111/j.1471-4159.2008.05837.x Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death
Clinical Neuropharmacology Nyholm 25 89 2002 10.1097/00002826-200203000-00006 Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations
Molecular and Cellular Biology Pap 22 578 2002 10.1128/MCB.22.2.578-586.2002 Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway
Toxicology Park 265 80 2009 10.1016/j.tox.2009.09.011 L-DOPA-induced neurotoxicity is reduced by the activation of the PI3K signaling pathway
Neurobiology of Disease Prigione 23 36 2006 10.1016/j.nbd.2006.01.013 Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage
Journal of Neurochemistry Shin 111 1042 2009 10.1111/j.1471-4159.2009.06381.x Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study
Life Science Soliman 72 185 2002 10.1016/S0024-3205(02)02204-X Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells
Experimental Neurology Steece-Collier 110 201 1990 10.1016/0014-4886(90)90031-M Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons
Stroke Sun 36 1672 2005 10.1161/01.STR.0000173406.04891.8c Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration
European Journal of Pharmacology Takadera 499 239 2004 10.1016/j.ejphar.2004.07.115 Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons
Journal of the Neurological Sciences Tanaka 101 198 1991 10.1016/0022-510X(91)90046-A Dopa and dopamine cause cultured neuronal death in the presence of iron
Journal of Experimental Medicine Villa 198 971 2003 10.1084/jem.20021067 Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis
Journal of Clinical Investigation Walkinshaw 95 2458 1995 10.1172/JCI117946 Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease
Apoptosis Wang 15 1470 2010 10.1007/s10495-010-0547-z Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling
Journal of Biological Chemistry Watcharasit 278 48872 2003 10.1074/jbc.M305870200 Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53
Molecular Pharmacology Watson 67 757 2005 10.1124/mol.104.004812 Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways
Journal of Biological Chemistry Wei 277 17649 2002 10.1074/jbc.M111704200 Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection
Apoptosis Wu 12 1365 2007 10.1007/s10495-007-0065-9 Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.